What is the recommended dose of saffron for treating depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Saffron for Depression

The recommended dosage of saffron for treating depression is 30 mg twice daily (total 60 mg/day) based on current evidence. 1

Evidence for Saffron in Depression Treatment

  • Saffron has demonstrated efficacy as a treatment for mild-to-moderate depression in clinical trials 2
  • A standardized saffron extract (affron®) at a dose of 14 mg twice daily (28 mg total) has shown effectiveness as an adjunctive treatment to pharmaceutical antidepressants in adults with persistent depression 3
  • In a double-blind, randomized, placebo-controlled trial, 50 mg saffron capsules twice daily for 12 weeks significantly improved depression scores compared to placebo 2
  • The Society for Integrative Oncology-ASCO guideline specifically mentions a positive low-risk-of-bias trial using 30 mg of saffron for depression 1

Mechanism of Action

  • Saffron appears to have antidepressant effects by potentially modulating dopamine release, which is particularly relevant for addressing anhedonia (lack of pleasure) in depression 4
  • Saffron may also influence BDNF-TrkB signaling, which is involved in the pathophysiology of depression 4

Comparative Effectiveness

  • Meta-analyses have shown that saffron supplementation results in significant reductions in Beck Depression Inventory (BDI) scores compared to placebo (Effect Size: -3.87; 95% CI: -5.27, -2.46) 5
  • Saffron has demonstrated a large positive effect size when compared with placebo for both depressive symptoms (g = 0.99, P < 0.001) and anxiety symptoms (g = 0.95, P < 0.006) 6
  • When used as an adjunct to antidepressants, saffron also showed a large positive effect size for depressive symptoms (g = 1.23, P = 0.028) 6

Clinical Considerations

  • For patients with mild depressive episodes, antidepressants are not recommended as initial treatment according to WHO guidelines, making saffron a potential alternative 1
  • For moderate to severe depression, saffron may be considered as an adjunct to conventional treatments such as tricyclic antidepressants (TCAs) or fluoxetine 1
  • If considering saffron as an adjunct to pharmaceutical antidepressants, monitor for potential reduction in antidepressant side effects, which has been reported in some studies 3

Treatment Duration

  • Based on conventional antidepressant guidelines, treatment should continue for at least 4-9 months after a satisfactory response for a first episode of depression 1
  • For patients who have had 2 or more episodes of depression, longer duration of therapy may be beneficial 1

Monitoring and Assessment

  • Begin assessing response and side effects within 1-2 weeks of initiating saffron treatment 1, 7
  • If there is inadequate response after 6-8 weeks, consider modifying the treatment approach 1
  • Use validated depression rating scales such as the Montgomery-Åsberg Depression Rating Scale (MADRS) or Beck Depression Inventory (BDI) to objectively measure treatment response 3, 2

Limitations and Caveats

  • Despite promising results, there is evidence of publication bias in saffron studies 6
  • Most studies have small sample sizes and relatively short durations 4
  • Saffron may not be appropriate as a standalone treatment for severe depression where conventional antidepressants are indicated 1
  • Quality and standardization of saffron extracts may vary between products, potentially affecting clinical outcomes 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.